Advance in radiotherapy of cervical carcinoma

Abstract

CHEN Jie, JIANG Bo, WANG Ping. Advance in radiotherapy of cervical carcinoma[J]. Journal of International Oncology, 2014, 41(3): 223-225.

［1］ Karen L, William S, Lorraine P, et al. Consensus guidelines for delineation of clinical target volume for intensitymodulated pelvic radiotherapy for the definitive treatment of cervical cancer［J］. Int J Radiat Oncol Biol Phys, 2011, 79(2):348355. ［2］ Small WJ, Mell LK, Anderson P, et al. Consensus guidelines for delineation of clinical target volume for intensitymodulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer［J］. Int J Radiat Oncol Biol Phys, 2008, 71(2):428434. ［3］ Toita1 T, Ohno T, Kaneyasu Y，et al. A consensusbased guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer［J］. Jpn J Clin Oncol, 2010, 40(5):456463. ［4］ Klopp AH, Eifel PJ. Chemoradiotherapy for cervical cancer in 2010［J］. Curr Oncol Rep, 2011, 13(1):7785. ［5］ Wang N, Guan QL, Wang K, et al. Radiochemotherapy versus radiotherapy in locally advanced cervical cancer: a metaanalysis［J］. Arch Gynecol Obstet, 2011, 283(1):103108. ［6］ Viswanathan AN， Creutzberg CL, Craighead P, et al. International Brachytherapy Practice Patterns: A Survey of the gynecologic cancer intergroup (GCIG)［J］. Int J Radiat Oncol Biol Phys, 2012, 82(1):250255. ［7］ Gondi V， Bentzen SM， Sklenar KL， et al. Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: An Interera Analysis［J］. Int J Radiat Oncol Biol Phys, 2012, 84(4):973982. ［8］ Isohashi F， Yoshioka Y， Mabuchi S, et al. Dosevolume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative concurrent nedaplatinbased chemoradiation therapy for earlystage cervical cancer［J］. Int J Radiat Oncol Biol Phys, 2013, 85(3):728734. ［9］ Biewenga P, Velden J, Mol BW, et al. Prognostic model for survival in patients with early stage cervical cancer［J］. Cancer, 2011, 117(4):768776.

[1]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[4]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[5]	Qian Xiaotao, Shi Ziyi, Hu Ge.A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(3): 151-156.
[6]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174.
[7]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42.
[8]	Cui Tenglu, Lyu lu, Sun Pengfei.Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2023, 50(9): 548-552.
[9]	Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying.Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer[J]. Journal of International Oncology, 2023, 50(8): 475-483.
[10]	Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367.
[11]	Lyu Lu, Sun Pengfei.Gut flora and cervical cancer[J]. Journal of International Oncology, 2023, 50(6): 373-376.
[12]	Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association, Radiation Oncology Therapy Branch, Chinese Medical Association, Chinese Association of Radiation Therapy, China Anti-Cancer Association.Chinese experts' consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy （2023 version）[J]. Journal of International Oncology, 2023, 50(4): 193-201.
[13]	Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng.Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance[J]. Journal of International Oncology, 2023, 50(4): 227-230.
[14]	Shi Xaioqi, Wang Hongyan.Research progress on the interaction between gut microbiota and radiation enteritis[J]. Journal of International Oncology, 2023, 50(4): 244-247.
[15]	Zhao Yongrui, Gao Ying, Chen Yidong, Xu Jiankun.Efficacy and safety of linear accelerator-based fractionated stereotactic radiotherapy for small volume brain metastases[J]. Journal of International Oncology, 2023, 50(3): 138-143.

Advance in radiotherapy of cervical carcinoma

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments